Automated description from the Alliance of Genome Resources (Release 7.0.0)
Predicted to enable RNA polymerase II-specific DNA-binding transcription factor binding activity. Acts upstream of or within several processes, including negative regulation of axonogenesis; skeletal muscle tissue regeneration; and striated muscle tissue development. Located in nucleus and sarcoplasm. Is expressed in several structures, including extraembryonic component; liver and biliary system; nasal cavity epithelium; nervous system; and tooth. Orthologous to human IFRD1 (interferon related developmental regulator 1).